CRISPR-Cas tools for simultaneous transcription & translation control in bacteria. | Cardiff RAL, Faulkner ID, Beall JG, Carothers JM, Zalatan JG | Nucleic Acids Res. 2024 May 22;52(9):5406-5419. doi: 10.1093/nar/gkae275. |
CRISPR-Cas-Mediated Chemical Control of Transcriptional Dynamics in Yeast. | Cunningham-Bryant D, Sun J, Fernandez B, Zalatan JG | Chembiochem. 2019 Jun 14;20(12):1519-1523. doi: 10.1002/cbic.201800823. Epub 2019 Apr 26. |
Effective CRISPRa-mediated control of gene expression in bacteria must overcome strict target site requirements. | Fontana J, Dong C, Kiattisewee C, Chavali VP, Tickman BI, Carothers JM, Zalatan JG | Nat Commun. 2020 Apr 1;11(1):1618. doi: 10.1038/s41467-020-15454-y. |
Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants. | Kiattisewee C, Karanjia AV, Legut M, Daniloski Z, Koplik SE, Nelson J, Kleinstiver BP, Sanjana NE, Carothers JM, Zalatan JG | ACS Synth Biol. 2022 Nov 15. doi: 10.1021/acssynbio.2c00405. |
Portable bacterial CRISPR transcriptional activation enables metabolic engineering in Pseudomonas putida. | Kiattisewee C, Dong C, Fontana J, Sugianto W, Peralta-Yahya P, Carothers JM, Zalatan JG | Metab Eng. 2021 Apr 27. pii: S1096-7176(21)00063-X. doi: 10.1016/j.ymben.2021.04.002. |
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria. | Dong C, Fontana J, Patel A, Carothers JM, Zalatan JG | Nat Commun. 2018 Jun 27;9(1):2489. doi: 10.1038/s41467-018-04901-6. |
The Axin scaffold protects the kinase GSK3beta from cross-pathway inhibition. | Gavagan M, Jameson N, Zalatan JG | Elife. 2023 Aug 7;12:e85444. doi: 10.7554/eLife.85444. |
The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions. | Gavagan M, Fagnan E, Speltz EB, Zalatan JG | Cell Syst. 2020 Jun 24;10(6):515-525.e5. doi: 10.1016/j.cels.2020.05.002. Epub 2020 Jun 17. |